Deferasirox for the treatment of iron overload associated with regular blood transfusions (transfusional haemosiderosis) in patients suffering with chronic anaemia: a systematic review and economic evaluation

Objectives: To assess the clinical effectiveness and cost-effectiveness of deferasirox for the treatment of iron overload associated with regular blood transfusions in patients with chronic anaemia such as beta-thalassaemia major (beta-TM) and sickle cell disease (SCD). Data sources: Electronic data...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: C McLeod, N Fleeman, J Kirkham, A Bagust, A Boland, P Chu, R Dickson, Y Dundar, J Greenhalgh, B Modell, A Olujohungbe, P Telfer, T Walley
التنسيق: Artigo
اللغة:Inglês
منشور في: NIHR Journals Library 2009-01-01
سلاسل:Health Technology Assessment
الموضوعات:
deferasirox
iron-overload
sickle-cell-disease
beta-thalassaemia
transfusionalhaemosiderosis
iron-chelating-agent
الوصول للمادة أونلاين:https://doi.org/10.3310/hta13010
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة